In silico pharmacogenetics of warfarin metabolism
Open Access
- 5 May 2006
- journal article
- research article
- Published by Springer Nature in Nature Biotechnology
- Vol. 24 (5) , 531-536
- https://doi.org/10.1038/nbt1195
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Effect ofVKORC1Haplotypes on Transcriptional Regulation and Warfarin DoseNew England Journal of Medicine, 2005
- IDENTIFICATION OF GLUTATHIONE-DERIVED METABOLITES FROM AN IP RECEPTOR ANTAGONISTDrug Metabolism and Disposition, 2004
- In Silico Genetics: Identification of a Functional Element Regulating H2 - E α Gene ExpressionScience, 2004
- Isolated EBV lymphoproliferative disease in a child with Wiskott-Aldrich syndrome manifesting as cutaneous lymphomatoid granulomatosis and responsive to anti-CD20 immunotherapyJournal of Clinical Pathology, 2003
- Cutaneous Lymphomatoid GranulomatosisThe American Journal of Surgical Pathology, 2001
- Oxidative Hydrolysis of Scoparone by Cytochrome P450 CYP2C29 Reveals a Novel MetaboliteBiochemical and Biophysical Research Communications, 2001
- Proliferation and Cellular Phenotype in Lymphomatoid GranulomatosisThe American Journal of Surgical Pathology, 1998
- Lymphomatoid granulomatosis of the skin and lung. An angiocentric T-cell-rich B-cell lymphoproliferative disorderArchives of Dermatology, 1996
- Evidence for a Proliferation of Epstein-Barr Virus Infected B-Lymphocytes with a Prominent T-Cell Component and VasculitisThe American Journal of Surgical Pathology, 1994
- Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9Pharmacogenetics, 1994